Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Derde generatie anti-CD19 CAR T-cellen voor gerecidiveerde/refractaire CLL
jan 2025 | Leukemie, Lymfoom